CIDD Program
- Program Objective
- This program provides consulting services to address regulatory challenges in new drug R&D projects and to help define the direction and strategy for drug development. Through this, the initiative seeks to increase the likelihood of development success and shorten the overall development timeline.
- Program Details
- Program period: Mar-Nov, 2026
- Scope of Support: CIDD-MFDS Program
- Selects globally innovative new drug projects and offers regulatory consulting aligned with MFDS (Ministry of Food and Drug Safety) pre-consultation requirements.
- Covers all consulting costs to help projects meet regulatory expectations efficiently.
- Contact
R&D Enabling & Strategy Team: rnd_project@kddf.org